Professor Ronald Ma’s research focuses on the epidemiology and genetics of diabetes and its complications, gestational diabetes, and precision medicine in diabetes. He has published over 500 research articles in international peer-reviewed journals, and has been involved in a large number of clinical trials evaluating new treatments for diabetes and diabetic kidney disease. Dr Ma plays an active role in diabetes advocacy. He has served on expert panels for the World Health Organization, the International Diabetes Federation (IDF), the International Federation of Gynecology and Obstetrics (FIGO) Pregnancy and NCD Committee, as well as serving as council member of the Asian Association for the Study of Diabetes (AASD). He received the Xiaoren Pan Distinguished Research Award for Epidemiology of Diabetes in Asia from the AASD in 2020. He led the precision prognostic workgroup for the ADA/EASD Precision Medicine in Diabetes Initiative. He is a council member of the Hong Kong College of Physicians. Locally he is working with a local charity, Youth Diabetes Action, to improve access to diabetes technology for young people with diabetes in Hong Kong.

Timothy Davis is an endocrinologist and general physician based at Fremantle Hospital, and Professor of Medicine at the University of Western Australia. He is principal investigator of the Fremantle Diabetes Study, a large-scale prospective study of diabetes in a community-based cohort, and has been as Associate Investigator in the UK Prospective Diabetes Study. Professor Davis is author or co-author of more than 540 original peer-reviewed research papers. He has participated in a number of key diabetes intervention trials including SUSTAIN-6 and SURPASS-4. He is a member and past Vice President of the Australian Diabetes Society, was the Society’s 2014 Kellion Lecturer in recognition of his outstanding contribution to diabetes research and clinical care in Australia. He was recently a member of the Australian Government’s Commonwealth Science Council and Co-Deputy Chair of the Australian Government Medical Services Advisory Committee.

Timothy Davis is an endocrinologist and general physician based at Fremantle Hospital, and Professor of Medicine at the University of Western Australia. He is principal investigator of the Fremantle Diabetes Study, a large-scale prospective study of diabetes in a community-based cohort, and has been as Associate Investigator in the UK Prospective Diabetes Study. Professor Davis is author or co-author of more than 540 original peer-reviewed research papers. He has participated in a number of key diabetes intervention trials including SUSTAIN-6 and SURPASS-4. He is a member and past Vice President of the Australian Diabetes Society, was the Society’s 2014 Kellion Lecturer in recognition of his outstanding contribution to diabetes research and clinical care in Australia. He was recently a member of the Australian Government’s Commonwealth Science Council and Co-Deputy Chair of the Australian Government Medical Services Advisory Committee.

Prof. Lim is a Senior Consultant Endocrinologist and Head of the Department of Research, Development, and Innovation at Universiti Malaya, Kuala Lumpur, Malaysia. She is the former Head of the Diabetes Care Unit, Universiti Malaya (2022-2025). She also holds honorary positions at the Chinese University of Hong Kong and the Baker Heart and Diabetes Institute, Melbourne, Australia. As a clinician-scientist, Prof. Lim’s major areas of interest are cardiometabolic medicine (epidemiology, molecular, and implementation science). Prof. Lim sits on the Scientific Work Groups of the American Diabetes Association/European Association for the Study of Diabetes (ADA/EASD) Precision Medicine in Diabetes Initiative and the World Health Organization (WHO) Global Diabetes Compact. She has published more than 130 peer-reviewed articles, including in The Lancet, Nature, Diabetes Care, and Science Bulletin. Prof. Lim has received several awards, including the 2025 Malaysia Scopus Research Start Award – Women in Research Excellence (STEM) Category, Universiti Malaya’s Top Cited Researcher 2024, World’s Top 2% Scientists by Stanford University for 4 consecutive years (2022-2025), and the European Foundation for the Study of Diabetes (EFSD) Albert Renold Fellowship, tenable at the University of Oxford, UK. She is an Editorial Board Member of several Tier 1 Web of Science-indexed journals. She is also the Vice President of Diabetes Malaysia (a country affiliate of the International Diabetes Federation) and the Council Member of the Malaysian Endocrine and Metabolic Society

Professor Ronald Ma’s research focuses on the epidemiology and genetics of diabetes and its complications, gestational diabetes, and precision medicine in diabetes. He has published over 500 research articles in international peer-reviewed journals, and has been involved in a large number of clinical trials evaluating new treatments for diabetes and diabetic kidney disease. Dr Ma plays an active role in diabetes advocacy. He has served on expert panels for the World Health Organization, the International Diabetes Federation (IDF), the International Federation of Gynecology and Obstetrics (FIGO) Pregnancy and NCD Committee, as well as serving as council member of the Asian Association for the Study of Diabetes (AASD). He received the Xiaoren Pan Distinguished Research Award for Epidemiology of Diabetes in Asia from the AASD in 2020. He led the precision prognostic workgroup for the ADA/EASD Precision Medicine in Diabetes Initiative. He is a council member of the Hong Kong College of Physicians. Locally he is working with a local charity, Youth Diabetes Action, to improve access to diabetes technology for young people with diabetes in Hong Kong.

Per-Henrik Groop is Professor and Chief Physician (Emeritus) at Department of Nephrology, University of Helsinki and Helsinki University Hospital, Guest Professor at Department of Diabetes, Monash University, and Baker Heart & Diabetes Institute, Melbourne, Australia. His research is focused on the pathogenesis of diabetic complications with special emphasis on diabetic nephropathy. In order to provide a unique set of clinical resources he initiated the large, nationwide FinnDiane Study in 1997. Professor Groop has published 540 peer-reviewed original articles in high-impact journals, 44 reviews and book chapters, as well as 800 abstracts presented at major international meetings.